Relay Therapeutics, Inc.RLAYNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-251.13M
↓ 60% below average
Average (6y)
$-156.62M
Historical baseline
Range
High:$-45.82M
Low:$-304.44M
CAGR
+32.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-251.13M | +17.5% |
| 2023 | $-304.44M | -27.6% |
| 2022 | $-238.55M | -206.3% |
| 2021 | $-77.88M | +25.4% |
| 2020 | $-104.42M | -40.9% |
| 2019 | $-74.14M | -61.8% |
| 2018 | $-45.82M | - |